Brave Asset Management Inc Merck & Co., Inc. Transaction History

Brave Asset Management Inc

$392 Million
Q2 2024

A detailed history of Brave Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brave Asset Management Inc holds 12,295 shares of MRK stock, worth $1.45 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

12,295

Previous 11,764 4.51%

Holding current value

$1.45 Million

Previous $1.55 Million 1.93%

% of portfolio

0.39%

Previous 0.4%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$123.8 - $132.96 $65,737 - $70,601	531 Added 4.51%	12,295 $1.52 Million
Q1 2024 Apr 29, 2024	SELL	$113.24 - $131.95 $1,472 - $1,715	-13 Reduced 0.11%	11,764 $1.55 Million
Q3 2023 Oct 13, 2023	SELL	$102.95 - $114.33 $12,868 - $14,291	-125 Reduced 1.05%	11,777 $1.21 Million
Q3 2022 Oct 13, 2022	SELL	$84.53 - $94.96 $386,217 - $433,872	-4,569 Reduced 27.74%	11,902 $1.03 Million
Q2 2022 Jul 15, 2022	SELL	$83.49 - $94.64 $165,477 - $187,576	-1,982 Reduced 10.74%	16,471 $1.5 Million
Q1 2022 Apr 22, 2022	SELL	$73.51 - $82.4 $34,035 - $38,151	-463 Reduced 2.45%	18,453 $1.51 Million
Q4 2021 Jan 21, 2022	SELL	$72.28 - $90.54 $53,993 - $67,633	-747 Reduced 3.8%	18,916 $1.45 Million
Q3 2021 Nov 02, 2021	SELL	$71.68 - $78.83 $36,556 - $40,203	-510 Reduced 2.53%	19,663 $1.48 Million
Q2 2021 Jul 27, 2021	SELL	$70.31 - $77.77 $92,879 - $102,734	-1,321 Reduced 6.15%	20,173 $1.57 Million
Q4 2020 Jan 27, 2021	BUY	$71.77 - $79.65 $213,731 - $237,197	2,978 Added 16.08%	21,494 $1.76 Million
Q3 2020 Oct 19, 2020	SELL	$73.18 - $82.95 $3,439 - $3,898	-47 Reduced 0.25%	18,516 $1.54 Million
Q2 2020 Jul 23, 2020	SELL	$70.42 - $80.13 $11,760 - $13,381	-167 Reduced 0.89%	18,563 $1.44 Million
Q1 2020 Apr 16, 2020	SELL	$63.36 - $87.82 $46,252 - $64,108	-730 Reduced 3.75%	18,730 $1.44 Million
Q4 2019 Jan 17, 2020	SELL	$77.58 - $87.54 $49,263 - $55,587	-635 Reduced 3.16%	19,460 $1.77 Million
Q3 2019 Oct 24, 2019	SELL	$76.08 - $82.93 $45,267 - $49,343	-595 Reduced 2.88%	20,095 $1.69 Million
Q2 2019 Aug 05, 2019	SELL	$69.84 - $81.59 $410,379 - $479,422	-5,876 Reduced 22.12%	20,690 $1.74 Million
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $32,702 - $37,299	-470 Reduced 1.74%	26,566 $2.21 Million
Q2 2018 Jul 23, 2018	BUY	$50.83 - $59.72 $146,390 - $171,993	2,880 Added 11.92%	27,036 $1.64 Million
Q1 2018 Apr 26, 2018	BUY	$50.96 - $59.23 $58,756 - $68,292	1,153 Added 5.01%	24,156 $1.32 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $1.35 Million - $1.45 Million	23,003	23,003 $1.47 Million

Others Institutions Holding MRK

# of Institutions

3,825

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $299B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.

Account

Brave Asset Management Inc Merck & Co., Inc. Transaction History